advertisement
Yuan H 17
Showing records 1 to 17 |
Display all abstracts from Yuan H104517 Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study)Gao X
BMJ open 2022; 12: e062441
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in ChinaSun X
BMC Ophthalmology 2022; 22: 332
104517 Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study)Lv A
BMJ open 2022; 12: e062441
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in ChinaLiu Q
BMC Ophthalmology 2022; 22: 332
104517 Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study)Lin F
BMJ open 2022; 12: e062441
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in ChinaTang X; Yao K
BMC Ophthalmology 2022; 22: 332
104517 Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study)Lu P; Zhang Y
BMJ open 2022; 12: e062441
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in ChinaLi Y; Yang J
BMC Ophthalmology 2022; 22: 332
104517 Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study)Song W; Zhu X
BMJ open 2022; 12: e062441
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in ChinaZhang M
BMC Ophthalmology 2022; 22: 332
104517 Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study)Zhang H
BMJ open 2022; 12: e062441
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in ChinaYuan H; Zheng Y
BMC Ophthalmology 2022; 22: 332
104517 Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study)Liao M; Song Y
BMJ open 2022; 12: e062441
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in ChinaLi W
BMC Ophthalmology 2022; 22: 332
104517 Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study)Hu K
BMJ open 2022; 12: e062441
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in ChinaPeng H
BMC Ophthalmology 2022; 22: 332
104517 Efficacy and safety of trabeculectomy versus peripheral iridectomy plus goniotomy in advanced primary angle-closure glaucoma: study protocol for a multicentre, non-inferiority, randomised controlled trial (the TVG study)Peng Y; Tang L; Yuan H; Xie L; Tang G; Nie X; Jin L; Fan S; Zhang X;
BMJ open 2022; 12: e062441
Issue 23-2
Change Issue
advertisement